SCHEMBL4591092

SCHEMBL4591092

O=Cc1ccc(N(Cc2ccc(Cl)cc2)C(=O)O)nc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
LMNA P02545 2/20 0.42
HSD17B10 Q99714 1/20 0.41
TRPM8 Q7Z2W7 2/20 0.40
BCL2A1 Q16548 3/20 0.39
TSHR P16473 1/20 0.39
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
GBA1 P04062 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1266484 0.83 LMNA (0.41) CYP1A2CYP3A4CYP2C9CYP2C19LMNA
SCHEMBL4588961 0.83 TRPM8 (0.42) CYP1A2LMNATRPM8TSHRPOLB
SCHEMBL4590950 0.80 TAS2R14 (0.45) LMNATRPM8TSHRPOLBSMN1; SMN2
SCHEMBL28661271 0.80 KCNH2 (0.41) LMNATRPM8TSHRPOLBSMN1; SMN2
SCHEMBL21294175 0.79 TRPM8 (0.35) CYP1A2CYP3A4CYP2C9CYP2C19LMNA
SCHEMBL20677823 0.74 ALDH1A1 (0.39) SMN1; SMN2KMT2AALDH1A1RAB9A
SCHEMBL12640354 0.71 ALDH1A1 (0.42) LMNAMEN1KMT2AALDH1A1RAB9A
SCHEMBL27765172 0.70 TACR2 (0.40) CYP1A2CYP3A4CYP2C9CYP2C19LMNA
SCHEMBL1267086 0.69 KDM4E (0.39) LMNATRPM8BCL2A1POLBSMN1; SMN2
SCHEMBL15652468 0.69 TRPM8 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008064265-A2 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR PLEXXIKON, INC. (US) 2008-05-29 WO disclosed